Tango Therapeutics stock surges on pancreatic cancer drug combo data
Colleen Cabi
·
2026-06-09
·
via Quartz
A combination of vopimetostat and Revolution Medicines' daraxonrasib produced a 92% response rate in patients…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。